TBK1-METTL3 axis facilitates antiviral immunity
Jingxuan Chen,Xuemei Wei,Xiao Wang,Tong Liu,Yingchi Zhao,Luoying Chen,Yujie Luo,Hongqiang Du,Yunfei Li,Tongtong Liu,Lili Cao,Zhe Zhou,Zeming Zhang,Ling Liang,Lu Li,Xuhui Yan,Xuehui Zhang,Xuliang Deng,Guang Yang,Ping Yin,Jianlei Hao,Zhinan Yin,Fuping You
DOI: https://doi.org/10.1016/j.celrep.2022.110373
IF: 8.8
2022-02-01
Cell Reports
Abstract:mRNA m<sup>6</sup>A modification is heavily involved in modulation of immune responses. However, its function in antiviral immunity is controversial, and how immune responses regulate m<sup>6</sup>A modification remains elusive. We here find TBK1, a key kinase of antiviral pathways, phosphorylates the core m<sup>6</sup>A methyltransferase METTL3 at serine 67. The phosphorylated METTL3 interacts with the translational complex, which is required for enhancing protein translation, thus facilitating antiviral responses. TBK1 also promotes METTL3 activation and m<sup>6</sup>A modification to stabilize IRF3 mRNA. Type I interferon (IFN) induction is severely impaired in METTL3-deficient cells. Mettl3<sup>fl/fl</sup>-lyz2-Cre mice are more susceptible to influenza A virus (IAV)-induced lethality than control mice. Consistently, Ythdf1<sup>-/-</sup> mice show higher mortality than wild-type mice due to decreased IRF3 expression and subsequently attenuated IFN production. Together, we demonstrate that innate signals activate METTL3 via TBK1, and METTL3-mediated m<sup>6</sup>A modification secures antiviral immunity by promoting mRNA stability and protein translation.
cell biology